Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERUCOV-VAC (TURKOVAC) Phase 2 in Healthy Adults
NCT04824391Phase 2Completed
- Sponsor
- TÜSEB
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of turkovac in coronavirus disease 2019 (COVID-19), sponsored by TÜSEB. Started Feb 2021; status: completed.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04824391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04824391.